SASHALEE STEWART: Open Payments
NPI 1093101222 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 114 payments from 14 companies in 2025. Trend: 2023 $549 · 2024 $2,234 · 2025 $2,156
Food & beverage: $2,147Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $392 |
| Otsuka America Pharmaceutical, Inc. | 17 | $330 |
| Janssen Pharmaceuticals, Inc | 4 | $218 |
| E.R. Squibb & Sons, L.L.C. | 19 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $169 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Teva Pharmaceuticals USA, Inc. | 6 | $124 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
Products named: REXULTI, VRAYLAR, SPRAVATO, COBENFY, TRINTELLIX, CAPLYTA, Auvelity, FANAPT.
Industry payments across NC — which companies pay providers there.
